SCHEMBL2378734

SCHEMBL2378734

CN(C)C1(c2cccc(F)c2)CCC(=CC(=O)NCCc2c[nH]c3ccccc23)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.55
TRPV1 Q8NER1 1/20 0.49
OPRM1 P35372 5/20 0.49
OPRL1 P41146 5/20 0.49
CDK4 P11802 3/20 0.49
CCND1 P24385 3/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
SIRT1 Q96EB6 1/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
PKM P14618 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
BLM P54132 1/20 0.46
KMT2A Q03164 1/20 0.46
BCHE P06276 1/20 0.46
ACHE P22303 1/20 0.46
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL303144 0.99 MAPT (0.55) MAPTTRPV1OPRM1OPRL1CDK4
SCHEMBL2379182 0.91 SIRT1 (0.53) MAPTTRPV1OPRM1OPRL1CDK4
SCHEMBL2378459 0.90 OPRL1 (0.59) MAPTOPRM1OPRL1NPC1RAB9A
Hydrochloric Acid SCHEMBL2380775 0.90 SIRT1 (0.52) MAPTTRPV1OPRM1OPRL1CDK4
SCHEMBL2379296 0.85 OPRL1 (0.55) OPRM1OPRL1CDK4NPC1RAB9A
SCHEMBL2378247 0.85 OPRM1 (0.43) MAPTOPRM1OPRL1CDK4CCND1
Hydrochloric Acid SCHEMBL302387 0.84 OPRM1 (0.42) MAPTOPRM1OPRL1CDK4CCND1
Hydrochloric Acid SCHEMBL2379642 0.84 OPRL1 (0.55) OPRM1OPRL1CDK4NPC1RAB9A
SCHEMBL2379415 0.84 OPRL1 (0.54) OPRM1OPRL1CDK4NPC1RAB9A
SCHEMBL2379955 0.83 OPRL1 (0.53) OPRM1OPRL1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017630-B2 Cyclohexylacetic acid compounds GRUENENTHAL GMBH (DE) 2011-09-13 US claimed
EP-1751093-B1 SUBSTITUTED CYCLOHEXYLACETIC ACID DERIVATIVES GRUENENTHAL GMBH (DE) 2010-10-06 EP claimed
US-20070129347-A1 Cyclohexylacetic acid compounds GRUENENTHAL GMBH (DE) 2007-06-07 US claimed
US-8017630-B2 Cyclohexylacetic acid compounds GRUENENTHAL GMBH (DE) 2011-09-13 US disclosed
EP-1751093-B1 SUBSTITUTED CYCLOHEXYLACETIC ACID DERIVATIVES GRUENENTHAL GMBH (DE) 2010-10-06 EP disclosed
US-20070129347-A1 Cyclohexylacetic acid compounds GRUENENTHAL GMBH (DE) 2007-06-07 US disclosed
EP-1751093-A1 SUBSTITUTED CYCLOHEXYLACETIC ACID DERIVATIVES Grünenthal GmbH (DE) 2007-02-14 EP disclosed
WO-2005110976-A1 SUBSTITUTED CYCLOHEXYLACETIC ACID DERIVATIVES Grünenthal GmbH (DE) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129347-A1 Cyclohexylacetic acid compounds ACACA, HCAR2, PCCA MAPT 1493/4885TRPV1 2670/4885OPRM1 3702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.